Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: A protocol for a multicentre comparative effectiveness study (CANRxPDA)

Souvik Mitra, Amish Jain, Joseph Y. Ting, Nadya Ben Fadel, Christine Drolet, Ayman Abou Mehrem, Amuchou Soraisham, Bonny Jasani, Deepak Louis, Anie Lapointe, Jon Dorling, Faiza Khurshid, Abbas Hyderi, Kumar Kumaran, Jaya Bodani, Dany Weisz, Ruben Alvaro, Mohammed Adie, Miroslav Stavel, Alyssa MorinSoume Bhattacharya, Jaideep Kanungo, Rody Canning, Xiang Y. Ye, Tara Hatfield, Courtney E. Gardner, Prakesh Shah

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
Original languageEnglish
Article numbere050682
JournalBMJ Open
Volume11
Issue number5
DOIs
Publication statusPublished - May 5 2021

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • neonatal intensive and critical care
  • neonatology
  • paediatric cardiology

Fingerprint

Dive into the research topics of 'Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: A protocol for a multicentre comparative effectiveness study (CANRxPDA)'. Together they form a unique fingerprint.

Cite this